Player FM - Internet Radio Done Right
Checked 1d ago
Aggiunto quattro anni fa
Contenuto fornito da Timothy Vreeland. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Timothy Vreeland o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
The AHPBA Podcast
Segna tutti come (non) riprodotti ...
Manage series 2966292
Contenuto fornito da Timothy Vreeland. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Timothy Vreeland o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Hosted by Tim Vreeland and Tim Newhook (@vreelant @timnewhook19). Interviews and discussions about topics in HPB surgery. Meant to engage members, and potential members, of the AHPBA.
…
continue reading
72 episodi
Segna tutti come (non) riprodotti ...
Manage series 2966292
Contenuto fornito da Timothy Vreeland. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Timothy Vreeland o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Hosted by Tim Vreeland and Tim Newhook (@vreelant @timnewhook19). Interviews and discussions about topics in HPB surgery. Meant to engage members, and potential members, of the AHPBA.
…
continue reading
72 episodi
Tutti gli episodi
×T
The AHPBA Podcast

1 Episode 29: Dr. D. Rohan Jeyarajah – Private Practice in HPB and the Modern Academic Surgeon 51:55
Today’s episode features a special guest, Dr. Rohan Jeyarajah. Dr. Jeyarajah is a hepatobiliary and complex GI surgeon, inaugural chair and professor of surgery at the TCU Burnett School of Medicine, and program director for the HPB and Complex GI surgical fellowships at Methodist System. He has a unique practice in the world of HPB, combining private practice and academics, which we were delighted to discuss today. Enjoy! Papers References in Episode: Jackson T, Lim JS, Cho E, Osman H, Nagatomo K, Jeyarajah DR. Hepatopancreatobiliary Fellowship Graduates: Where Do They Stand today? Am Surg. 2022 Jun;88(6):1250-1255. doi: 10.1177/0003134821995066. Epub 2021 Feb 10. PMID: 33565895.…
T
The AHPBA Podcast

1 Episode 28: Dr. Maithel – The Surgeon Scientist & Surgeon-Led Clinical Trials in Biliary Tract Cancer 1:00:42
1:00:42
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto1:00:42
Today’s episode features Dr. Shishir Maithel. Dr. Maithel is a hepatobiliary surgeon, professor of surgery, and chief of the division of Surgical Oncology at a Northwestern University. He holds multiple national leadership positions, including as chair of the gastrointestinal surgery working group of ECOG and a member of the scientific and medical advisory board of the international cholangiocarcinoma research network. Dr. Maithel leads multiple clinical trials in the field of HPB and we are excited today to discuss his many national and international research efforts. Enjoy! Papers Referenced in Episode: Maithel, S. K., Keilson, J. M., Cao, H. S. T., Rupji, M., Mahipal, A., Lin, B. S., ... & Rocha, F. G. (2023). NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma. Annals of surgical oncology , 30 (11), 6558-6566. Oh DY, Ruth He A, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Ah Lee M, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee CK, Takahashi H, Ikeda M, Chen JS, Wang J, Makowsky M, Rokutanda N, He P, Kurland JF, Cohen G, Valle JW. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1. PMID: 38319896. Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators. Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med. 2023 Jan 19;388(3):228-239. doi: 10.1056/NEJMoa2206834. PMID: 36652354. Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Erratum in: Lancet. 2023 Sep 16;402(10406):964. doi: 10.1016/S0140-6736(23)01904-9. Erratum in: Lancet. 2024 Mar 23;403(10432):1140. doi: 10.1016/S0140-6736(24)00545-2. PMID: 37075781. Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DVT, Borad MJ, Bridgewater JA, Harris WP, Murphy AG, Oh DY, Whisenant JR, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Chamberlain CX, Aguado-Fraile E, Choe S, Wu B, Liu H, Gliser C, Pandya SS, Valle JW, Abou-Alfa GK. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial. JAMA Oncol. 2021 Nov 1;7(11):1669-1677. doi: 10.1001/jamaoncol.2021.3836. PMID: 34554208; PMCID: PMC8461552. Harding JJ, Fan J, Oh DY, Choi HJ, Kim JW, Chang HM, Bao L, Sun HC, Macarulla T, Xie F, Metges JP, Ying J, Bridgewater J, Lee MA, Tejani MA, Chen EY, Kim DU, Wasan H, Ducreux M, Bao Y, Boyken L, Ma J, Garfin P, Pant S; HERIZON-BTC-01 study group. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study. Lancet Oncol. 2023 Jul;24(7):772-782. doi: 10.1016/S1470-2045(23)00242-5. Epub 2023 Jun 2. PMID: 37276871. Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Erratum in: Lancet Oncol. 2019 May;20(5):e242. doi: 10.1016/S1470-2045(19)30216-5. PMID: 30922733. Clinical Trials: https://clinicaltrials.gov/study/NCT05514912 (The OPTIC Trial) https://clinicaltrials.gov/study/NCT03579758?cond=gallbladder%20cancer&term=maithel&rank=1 (Chemotherapy Before & After Surgery in Patients with Resectable Gallbladder Cancer)…
T
The AHPBA Podcast

We are excited to welcome Dr. Guido Torzilli to the podcast! Dr. Torzilli is a world-renowned hepatobiliary surgeon and Professor of Surgery at Humanitas University in Milan, Italy. In this episode, we have a fantastic conversation about his career, the concepts that have shaped his extraordinary and innovative approach to liver surgery, and much more!…
T
The AHPBA Podcast

1 Episode 26: Dr. David Iannitti—Innovation in Surgery and the Past, Present, and Future of Liver Ablation 1:06:38
1:06:38
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto1:06:38
We are excited to welcome Dr. David Iannitti to the podcast! Dr. Iannitti is a hepatobiliary surgeon, professor of surgery, program director of the HPB fellowship, and the chief of the HPB Surgery Division at Atrium Health in Charlotte, North Carolina. His clinical and research interests include the pathophysiology of hepatocellular carcinoma and other therapies for liver lesions. We’re excited to share a fantastic conversation discussing history and innovations of electrosurgery, novel therapies for liver disease, and much more! Papers Referenced in Episode: Swan, R. Z., Tsirline, V., Sindram, D., Martinie, J. B., & Iannitti, D. A. (2012). Fundamentals of microwave physics: application to hepatic ablation. Journal of Microwave Surgery , 30 , 25-40. Ricker AB, Baker EH, Strand MS, Kalabin A, Butano V, Wells A, Phillips M, Wang H, McKillop I, Iannitti G, Casingal J, Martinie JB, Vrochides D, Iannitti DA. Surgical microwave ablation for the treatment of hepatocellular carcinoma in 791 operations. HPB (Oxford). 2024 Mar;26(3):379-388. doi: 10.1016/j.hpb.2023.11.009. Epub 2023 Nov 25. PMID: 38102029. Wells AB, Butano VW, Phillips MC, Mckillop IH, Martinie JB, Baker EH, Iannitti DA. Outcomes after Surgical Microwave Ablation for the Treatment of Colorectal Liver Metastasis. J Am Coll Surg. 2024 Apr 23. doi: 10.1097/XCS.0000000000001097. Epub ahead of print. PMID: 38651746. Davis JM, Salibi PN, Motz BM, Vrochides D, McKillop IH, Iannitti DA. Irreversible Electroporation-Assisted Resection for Locally Advanced Pancreas Cancer. Surg Innov. 2023 Jun;30(3):332-339. doi: 10.1177/15533506231157442. Epub 2023 Feb 15. PMID: 36792137.…
T
The AHPBA Podcast

The early career group of IHPBA presents recording from discussions at the Early Career Retreat and ECG Lounge sessions from the 2024 IHPBA World Congress in Cape Town. In this episode, we join the ECG Lounge where past and current presidents of HPB surgery societies talk with early career IHPBA attendees about how to get involved in surgical societies like the IHPBA. Listen to Drs. Marc Besselink (president of EAHPBA), Sean Cleary (immediate past president of AHPBA), Rebecca Minter (past president of AHPBA), and Shailesh Shrikhande (president of APHPBA) answer questions from early career surgeons and provide advice on how to engage in surgical societies. Discussions are moderated by Drs. Mary Dillhoff and Janet Kung.…
Join us for another episode of our series ECG Overtime, hosted by the E-AHPBA/IHPBA Early Career Group! This episode features Dr. Sanket Srinivasa, Dr. Tay Wee Ming, and Dr. Saneya Pandrowala. Enjoy an episode in which we continue the conversation started during the Asia/Pacific Webinar about life beyond surgery as a new HPB surgeon!…
T
The AHPBA Podcast

1 Latín América-Episodio #35. Dr. Roberto Hernandez Alejandro. Transplante of Colorectal Liver Metastasis. 1:24:15
1:24:15
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto1:24:15
El Dr. Roberto Hernandez-Alejandro ha sido Jefe de la División de Trasplantes en la Universidad de Rochester desde agosto de 2016. Bajo su liderazgo, expandió las oportunidades de trasplante mediante el aumento del uso de órganos donados después de la muerte cardíaca. Recientemente, el Dr. Hernandez abrió un programa de trasplante hepático para metástasis hepáticas de cáncer colorrectal irresecable, siendo actualmente el centro líder en volumen y resultados en América del Norte. También tiene experiencia en resecciones hepáticas y es uno de los pocos cirujanos en Estados Unidos que realiza el procedimiento ALPPS.…
T
The AHPBA Podcast

1 ECG Overtime: Episode 5 - Live from Cape Town - International Collaborations: The GECKO Model 23:37
The early career group of IHPBA presents recording from discussions at the Early Career Retreat and ECG Lounge sessions from the 2024 IHPBA World Congress in Cape Town. In this episode, Drs. Ewen Harrison and Deirdre Kruger review opportunities and lessons learned from international collaborations in global surgical research, using the example of the GlobalSurg network and the GECKO study, along with moderators Drs. Timothy Newhook and Julia Menso.…
T
The AHPBA Podcast

The early career group of IHPBA presents recording from discussions at the Early Career Retreat and ECG Lounge sessions from the 2024 IHPBA World Congress in Cape Town. In this episode, we discuss challenges and controversies in the editorial process, with a focus on the involvement of trainees and early career surgeons, with Drs. Giovanni Marchegiani, Rachel Guest, and David Cavalucci, along with moderators Drs. Timothy Newhook and Julia Menso. Hear about how to get started and get credit for peer-review, select a journal for publication, and controversies about sustainability of the current publishing model. Should peer-reviewers be compensated? Should we move towards fully open access publishing? Should we get rid of impact factors?…
T
The AHPBA Podcast

The early career group of IHPBA presents a recording from discussions at the Early Career Retreat and ECG Lounge sessions from the 2024 IHPBA World Congress in Cape Town. In this episode, Dr. Stephen Wigmore, Editor-in-Chief of HPB, reviews tips to get a manuscript published, with moderators Drs. Timothy Newhook and Julia Menso.…
T
The AHPBA Podcast

Today’s episode features Dr. Anushi Shah and Dr. Michele Babicky, discussing the hot topic of training paradigms in HPB. Dr. Babicky is a surgical oncologist and assistant professor of surgery at Providence Portland Medical Center. She is the program director of the HPB fellowship at her institution, with a passion for surgical education. Dr. Babicky is accompanied by her HPB fellow, Dr. Anushi Shah. Dr. Shah comes to us with a unique perspective in HPB training as a just recently graduated HPB fellow (after this episode was recorded) at Providence Portland Medical Center after graduating in 2022 from a transplant fellowship at MGH. We are very excited for an enthusiastic discussion about training pathways in HPB. Enjoy! References: Miller P, Romero-Hernandez F, Mora RV, Hughes D, Babicky M, Warner S, Alseidi A, Visser B; AHPBA SWOT Taskforce. AHPBA senior leaders' assessments of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery: "We need to standardize our training experiences". HPB (Oxford). 2022 Dec;24(12):2054-2062. doi: 10.1016/j.hpb.2022.09.014. Epub 2022 Oct 1. PMID: 36270938. Romero-Hernandez F, Miller P, Mora RV, Hughes D, Warner S, Alseidi A, Visser B, Babicky M; AHPBA SWOT Taskforce. AHPBA graduated fellows' assessments of strengths, weaknesses, opportunities and threats facing fellowship training in HPB surgery: "HPB training excellence means volume, knowledge, and mentorship". HPB (Oxford). 2022 Dec;24(12):2063-2071. doi: 10.1016/j.hpb.2022.09.015. Epub 2022 Oct 1. PMID: 36333230. Hughes D, Romero Hernandez F, Miller P, Warner S, Babicky M, Visser B, Alseidi A; AHPBA SWOT Taskforce. The job market for HPB surgeons: leadership perspectives on surgeon skillsets, training pathways, and hiring. HPB (Oxford). 2022 Dec;24(12):2072-2081. doi: 10.1016/j.hpb.2022.09.017. Epub 2022 Oct 3. PMID: 36307255. Warner SG, Babicky M, Alseidi A, Visser B; AHPBA SWOT Taskforce. Conclusions and recommendations of an AHPBA-commissioned assessment of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery. HPB (Oxford). 2022 Dec;24(12):2082-2085. doi: 10.1016/j.hpb.2022.09.004. Epub 2022 Sep 27. PMID: 36243631.…
T
The AHPBA Podcast

1 Latín América-Episodio #34. Dr. George Molina. Checklist, Blackbox, Cirugia de Pancreas y mas. 54:07
El Dr. Molina se graduó de la Universidad Johns Hopkins con una licenciatura en biología celular y molecular. Obtuvo su título de médico en la Facultad de Medicina de Harvard y completó una maestría en Métodos Cuantitativos en la Escuela de Salud Pública T. H. Chan de Harvard. Realizo residencia en Cirugía General en el Hospital General de Massachusetts (MGH) y una beca en Oncología Quirúrgica General Compleja en el Hospital Brigham and Women's/MGH y el Instituto del Cáncer Dana-Farber. Con el Dr Molina, conversamos de su trabajo en Ariadne Labs, Blackbox y mucho mas. Espero disfruten la entrevista!…
T
The AHPBA Podcast

1 Episode 24: Dr. Bas Groot Koerkamp—Clinical Trials in Pancreatic Cancer and The Dutch Pancreatic Cancer Group 1:07:32
1:07:32
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto1:07:32
Today’s episode is a special in-person interview with Dr. Newhook and Dr. Bas Groot Koerkamp! Dr. Koerkamp is a hepatobiliary surgeon and researcher within the HPB and Transplantation Surgery department of Erasmus University Medical Center in Rotterdam, Netherlands. Dr. Groot Koerkamp leads several national clinical studies with the Dutch Pancreatic Cancer Group, including the PREOPANC studies, which we are thrilled to discuss in today’s episode! Enjoy! Papers Referenced in the Episode: Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ; Dutch Pancreatic Cancer Group. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27. PMID: 35084987. Janssen, Q.P., van Dam, J.L., Bonsing, B.A. et al. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer 21, 300 (2021). https://doi.org/10.1186/s12885-021-08031-z Janssen, Q., van Dam, J. L., Besselink, M. G., Homs, M. Y., van Tienhoven, G., Wilmink, J. W., ... & Dutch Pancreatic Cancer Group. (2021). Total neoadjuvant FOLFIRINOX or gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2): A nationwide multicenter randomized controlled trial. Janssen QP, van Dam JL, Bonsing BA, Bos H, Bosscha KP, Coene PPLO, van Eijck CHJ, de Hingh IHJT, Karsten TM, van der Kolk MB, Patijn GA, Liem MSL, van Santvoort HC, Loosveld OJL, de Vos-Geelen J, Zonderhuis BM, Homs MYV, van Tienhoven G, Besselink MG, Wilmink JW, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer. 2021 Mar 23;21(1):300. doi: 10.1186/s12885-021-08031-z. PMID: 33757440; PMCID: PMC7989075. Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Eijck CH, van Tienhoven G; Dutch Pancreatic Cancer Group. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol. 2020 Jun 1;38(16):1763-1773. doi: 10.1200/JCO.19.02274. Epub 2020 Feb 27. PMID: 32105518; PMCID: PMC8265386. https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/july-2022-volume-107-number-7/alliance-a021806-a-phase-iii-trial-of-perioperative-vs-adjuvant-chemotherapy-for-resectable-pancreatic-cancer/ Franssen, S., Van Driel, L. M., Moelker, A., & Groot Koerkamp, B. (2023). Primary percutaneous stenting above the ampulla for palliative biliary drainage of malignant hilar biliary obstruction.…
T
The AHPBA Podcast

1 ECG Overtime: Episode 2 - Starting a Robotics Program & Harnessing Multicenter Collaborations 37:01
Join us for the second episode of our series ECG Overtime, hosted by the E-AHPBA/IHPBA Early Career Group! This episode features Dr. Leanne Prodehl, Dr. Sanket Srinivasa, Dr. Rachel Moore, and Dr. Niki Rashidian. Join us in continuing a conversation from the ECG Roadshow—starting a robotic HPB program and collaborating on multicenter research projects!…
T
The AHPBA Podcast

1 Episode 23: Dr. Ching-Wei Tzeng – HPB Education, Quality Improvement, and Preoperative Use of Y-90 in CRLM 59:06
Today’s episode features Dr. Ching-Wei Tzeng. Dr. Tzeng is a hepatobiliary surgeon and Associate Professor of Surgical Oncology at MD Anderson. Among many roles, he is the Department Vice Chair of Clinical Operations and Program Director for the HPB Surgery Fellowship. Dr. Tzeng is an accomplished researcher. His interests focus on multimodality therapy for GI Cancers and perioperative quality improvement, including cancer surgery standards, patient-centered opioid reduction protocols, and quality of life measures. Dr. Tzeng is a passionate surgical educator and has been widely recognized with numerous teaching awards. In this episode we discuss topics including surgical education, quality improvement from the surgeon to institution level, and much more. Enjoy! Papers/Trials Referenced in the Episode: DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 Jul 1;235(1):41-48. doi: 10.1097/XCS.0000000000000231. Epub 2022 Apr 11. PMID: 35703961; PMCID: PMC9205619. Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg. 2020 Dec 1;155(12):1166-1167. doi: 10.1001/jamasurg.2020.3527. PMID: 32997105; PMCID: PMC7527936. Preoperative Y90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients with Colorectal Liver Metastases: https://classic.clinicaltrials.gob/ct2/show/NCT05195710…
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.